Related Experiment Video

Updated: Oct 30, 2025

High Content Screening in Neurodegenerative Diseases
13:32

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

17.7K

Cytoprotective Mechanisms of DJ-1: Implications in Cardiac Pathophysiology

James N Tsoporis1, Ioannis-Alexandros Drosatos2, Sahil Gupta1,3

  • 1Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, ON M5B 1W8, Canada.

Molecules (Basel, Switzerland)
|July 2, 2021
PubMed

Insights

DJ-1 (also known as PARK7) is linked to Parkinson's disease but also protects against cardiovascular disease. Increased DJ-1 expression shows anti-apoptotic and anti-inflammatory effects after cardiac surgery.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiovascular Research

Background:

  • DJ-1 (PARK7) is implicated in Parkinson's disease pathogenesis.
  • DJ-1 has diverse functions beyond the central nervous system.
  • Emerging evidence highlights DJ-1's protective role in ischemia-reperfusion injury and cardiovascular disease.

Purpose of the Study:

  • To review current knowledge on DJ-1's role in cardiovascular function.
  • To identify gaps in understanding DJ-1's cardiovascular involvement.
  • To present original data on DJ-1 expression post-cardiac surgery.

Main Methods:

  • Literature review of DJ-1 in cardiovascular disease.
  • Analysis of original data on DJ-1 expression.
  • Correlation of DJ-1 levels with anti-apoptotic and anti-inflammatory markers.

Main Results:

  • DJ-1 expression is associated with cardiovascular protection.
  • Increased DJ-1 correlates with enhanced anti-apoptotic markers post-cardiac surgery.
  • DJ-1 expression is linked to reduced inflammation in cardiovascular contexts.

Conclusions:

  • DJ-1 plays a significant role in regulating cardiovascular function.
  • DJ-1 exhibits protective effects against cardiovascular injury.
  • DJ-1 represents a potential therapeutic target for cardiovascular diseases.
Keywords:
DJ-1antioxidantapoptosisheart failureinflammation

More Related Videos

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish08:09

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

10.0K
Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk05:15

Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk

Published on: July 27, 2022

1.8K

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.4K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
101
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
951
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
121
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
123